Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019:57:160-162.
doi: 10.1016/j.ijscr.2019.03.035. Epub 2019 Mar 30.

Small gastrointestinal stromal tumour of the duodenum causing a life-threatening bleeding - A case report and review of the literature

Milena Taskovska  1 , Mirko Omejc  2 , Jan Grosek  3
Affiliations

Small gastrointestinal stromal tumour of the duodenum causing a life-threatening bleeding - A case report and review of the literature

Milena Taskovska et al. Int J Surg Case Rep. 2019.

Abstract

Introduction: Duodenal gastrointestinal stromal tumors (DGISTs) are mesenchymal tumors. Main presenting symptoms are gastrointestinal bleeding and non-specific abdominal pain. Surgical treatment is golden standard for treatment of DGISTs. Tumour location and size determine the surgical strategy. Recurrence rate depends on tumour location and completeness on removal.

Presentation of case: 75 years old male fell ill with hematemesis, hemohesia and dizziness. Oesophagogastroduodenoscopy (EGD) did not reveal the source of bleeding. Upon admission, a second EGD was performed due to loss of consciousness and anaemia, which revealed only approximate source of bleeding in the third portion of the duodenum. The exact bleeding spot could not be reached and bleeding could not be controlled endoscopically. Patient was transferred to the operating room for an emergency explorative laparotomy. After extensive mobilisation of the duodenum a 2 × 2 cm intraluminal tumour with central bleeding ulceration was found in D3. The diseased part of the duodenum was excised and the duodenotomy was closed with interrupted sutures. Final pathohistological report confirmed gastrointestinal stromal tumour, pT1. Postoperative period was uneventful.

Discussion: Gastrointestinal stromal tumours are most common in males aged 60-65 years. Surgical treatment is a golden standard. Surgical approach depends upon tumor location and size. In case of major bleeding surgical procedure is lifesaving and diagnostics for staging purposes are omitted.

Conclusion: Gastrointestinal stromal tumors are a potential source of life-threatening bleeding. In such cases an emergency operation is often indicated with aim to remove the tumour en bloc and achieve hemostasis as soon as possible.

Keywords: Bleeding; Case report; Duodenum; Gastrointestinal stromal tumor; Surgery.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Intraluminal tumor with central bleeding ulceration.
Fig. 2
Fig. 2
Repair of the duodenotomy with interrupted sutures.
Fig. 3
Fig. 3
Tumor after excision.
See this image and copyright information in PMC

References

    1. Shen C., Chen H., Yin Y., Chen J., Han J. Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome. BMC Surg. 2015 15.98. - PMC - PubMed
    1. Popivanov G., Tabakov M., Mantese G., Cirocchi R., Piccinini I. Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review. Transl. Gastroenterol. Hepatol. 2018;3:71. - PMC - PubMed
    1. Agha R.A., Borrelli M.R., Farwana R., Koshy K., Fowler A., Orgill D.P. For the SCARE group. The SCARE 2018 statement: updating consensus surgical case report (SCARE) guidelines. Int. J. Surg. 2018;60:132–136. - PubMed
    1. Valli V.P., Valli C., Pfammatter T., Bauerfeind P. Life-threatening bleeding of a duodenal gastrointestinal stromal tumor in a teenager: a rare case report. Endosc. Int. Open. 2016;04:E1244–E1246. - PMC - PubMed
    1. Nilsson B., Bu¨mming P., Meis-Kindblom J.M. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western Sweden. Cancer. 2005;103:821–829. - PubMed